3,4-Dihydro-2H-isoquinolin-1-one

• CAS: 1196-38-9
• Catalog Number: ACM1196389
• Category: Other Products
• Molecular Weight: 147.1762
• Molecular Formula: C9H9NO
• MDL Number: MFCD00853963

Synthetic Use

Upstream Synthesis Route 1

• 1269142-23-5

• 66655-67-2
• 1196-38-9

Reference: [1] Organic and Biomolecular Chemistry, 2011, vol. 9, # 3, p. 656 - 658

Upstream Synthesis Route 2

• 91-21-4

• 1196-38-9

Reference: [1]Location in patent: scheme or table
Preedasuriyachai, Patcharee; Chavasiri, Warinthorn; Sakurai, Hidehiro
[Synlett, 2011, # 8, p. 1121 - 1124]

Upstream Synthesis Route 3

• 6552-60-9

• 1196-38-9

Reference: [1]Girard; Atkinson; Belanger; et al.
[Journal of Organic Chemistry, 1983, vol. 48, # 19, p. 3220 - 3234]
[2]Singh, Harjit; Singh, Paramjit; Malhotra, Nageshwar
[Journal of the Chemical Society. Perkin transactions I, 1981, p. 2647 - 2649]
[3]Singh, Harjit; Singh, Paramjit; Malhotra, N.
[Synthetic Communications, 1980, vol. 10, # 8, p. 591 - 594]

Downstream Synthesis Route 1

• 1196-38-9

• 66491-03-0

Reference: [1] Journal of Medicinal Chemistry, 2002, vol. 45, # 16, p. 3394 - 3405

Downstream Synthesis Route 2

• 1196-38-9

• 91-21-4

Reference: [1]Current Patent Assignee: BASF SE; CIBA PHARMACEUTICAL PRODUCTS, INC. - DE824491, 1951, C
[DRP/DRBP Org.Chem.][DRP/DRBP Org.Chem.]
Current Patent Assignee: BASF SE; CIBA PHARMACEUTICAL PRODUCTS, INC. - US2781348, 1949, A
[2]Li, Jian; Wang, Zheng-Bing; Xu, Yue; Lu, Xue-Chen; Zhu, Shang-Rong; Liu, Li
[Chemical Communications, 2019, vol. 55, # 80, p. 12072 - 12075]
[3]Jing, Dong; Lu, Cong; Chen, Zhuo; Jin, Songyang; Xie, Lijuan; Meng, Ziyi; Su, Zhishan; Zheng, Ke
[Angewandte Chemie - International Edition, 2019, vol. 58, # 41, p. 14666 - 14672][Angew. Chem., 2019, vol. 131, p. 14808 - 14814,7]
[4]Hu, Xiwen; Li, Jian; Liu, Li; Xu, Yue; Zhu, Shangrong
[Organic Letters, 2020, vol. 22, # 24, p. 9478 - 9483]

* For details of the synthesis route, please refer to the original source to ensure accuracy.